Skip to Content

It’s an unsettling feeling to be living under the BRCA2+ cloud – to be a member of the tainted gene pool club. Most breast cancers are not directly linked to hereditary risk factors; rather most are considered to be sporadic. In fact, less than 10% are attributed to gene mutations. How did I land in …

Read More about Living Under the BRCA2+ Cloud

Gene patenting is in the news once again. This issue isn’t going away any time soon. In my opinion, this debate boils down to one simple question. Should one company, in this case, Myriad Genetics, be allowed to patent human genes when lives are at stake? It seems as if there is a simple answer here …

Read More about Future Status of BRCA1 & BRCA2 Gene Patents Remains Uncertain – Why Everyone Should Care

Last November I was contacted by a journalism student attending Emory University in Atlanta, Georgia. She was working on a paper about BRCA gene mutation testing, the monopolies held by two genetic testing companies and the recent controversial rulings on patents. She also wanted to include some thoughts and insights from a person directly influenced …

Read More about Monopolies, Rulings and Controversies on BRCA1 and BRCA2 Patents